the epitope sites specific to those antibodies are effectively blocked, preventing further binding by additional antibodies that share the same binding sites and sit within the same epitope space.

Kumamoto University researchers have identified a powerful antibody that can neutralize a wide range of SARS-CoV-2 variants, ...

Despite their potential, antibodies that target a specific epitope — a region of an antigen ... making it possible to optically detect when binding has occurred. For the past several years ...

AK0610 is engineered from an antibody isolated from a recovered infant and targets the pre-fusion F protein of RSV.

YUMAB uses libraries of close to germline origin, but highly diverse antigen-binding ... antibody-discovery process in vitro and bypassing animal immunization, YUMAB eliminates potential epitope ...

Transcenta Holding Limited, announced late-breaking presentation of preclinical study results of novel humanized LIV-1 ...

OmniAb, Inc. (NASDAQ: OABI) today announced that two presentations featuring the Company's technologies were delivered at the 2024 Antibody Engineering & Therapeutics Conference (AETC) underway in San ...